Gan & Lee Pharmaceuticals Sustainability Reports
Gan & Lee Pharmaceuticals specializes in the development, production, and commercialization of recombinant insulin analogs and other biopharmaceutical products. The company focuses heavily on diabetes treatment while expanding into metabolic, oncology, and medical device fields.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG001T8R883
6 reports from 2020 to 2025
